Researchers discusses the ways in which people’s quality of sleep may influence their daily symptoms of Alzheimer’s. We’ve probably all experienced how a poor…
The importance of good clinical research and good clinical care is greater than one might think. Emory University Alzheimer’s researcher Dr. Monica Parker shares…
On Monday, revealed that a phase 3 study of brexpiprazole — brand name Rexulti — in Alzheimer’s patients showed that the drug for major…
For Dale Rivard, practicing law and working as a trial attorney was his calling. Rivard’s diagnosis of mild cognitive impairment (MCI) in 2017, however,…
There were more than 140 experimental Alzheimer’s drugs in clinical trials as of the start of 2022. On the one hand, this number inspires…
UPDATE: 3 March 2024, 8:35 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Scientists have faced obstacle after obstacle in the search for effective Alzheimer’s drugs. While there are a number of symptomatic drugs approved by the…
Two researchers from Dalhousie University in Halifax — Jasmine Mah, an internal medicine resident and PhD candidate with a focus on geriatrics, and Kaitlin…
By 2050, it is estimated that 153 million people worldwide — more than one in every 100 — will be living with Alzheimer’s. While the…
How can a chronic condition originating from the pancreas double your risk of developing Alzheimer’s or dementia? According to the Centers for Disease Control…
Neurology and psychiatry professor Christopher Filley at the University of Colorado Anschutz Medical Campus shares insights from new research on brain’s gray matter and…
More than 60 percent of people with dementia are also diagnosed with depression. In some cases, studies indicate that depression might even cause the…
University of Colorado associate professor of health economics Joan O’Connell and University of California Irvine associate professor of epidemiology Luohua Jiang share insights from…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Shonda Bell — a special education…
A Phase 2a clinical trial is underway to test the possible benefits of sodium selenate for people living with frontotemporal dementia. While Alzheimer’s is…